Restylane Defyne

Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to initiation. Avoid intravascular inj; discontinue immediately if changes in vision, signs of stroke, blanching of skin or unusual pain during or shortly after procedure occurs. Avoid sites in close proximity to a permanent implant. Avoid implantation in or near blood vessels or vascular rich areas. Undergone prior surgical procedure in the planned treatment area. Risk of infection. Defer if active inflammatory process or infection is present at specific sites. Use in non-facial areas: not established. Possible risk of an inflammatory reaction at implant site if laser treatment, chemical peeling, or any other procedure based on active dermal response is considered after Restylane Defyne or if product is given before skin has healed completely after such a procedure. Hypertrophic scars formation or any other healing disorders. Bleeding disorders. Epilepsy. Impaired cardiac conduction. Risk of herpes reactivation in those with a history of herpetic eruption. Avoid excessive sun, UV lamp exposure, or extreme temperatures. Severe hepatic or renal impairment. Patients (<22yrs), pregnancy, nursing mothers: not established.